Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cervarix

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Pre-adolescent girls (9-15years) have the option of receiving a two dose HPV vaccine series at either a six month or one year… Expand
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND The current generation of Human Papillomavirus (HPV) vaccines, Cervarix® and Gardasil®, exhibit a high degree of… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Abstract▴ Cervarix™ is a prophylactic vaccine comprised of a mixture of virus-like particles derived from the L1 capsid proteins… Expand
  • figure 1
  • figure 2
Is this relevant?
2012
2012
BACKGROUND We previously demonstrated that Cervarix(®) elicits antibody responses against vaccine-related types for which… Expand
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
  • MMWR. Morbidity and mortality weekly report
  • 2010
  • Corpus ID: 25045168
On October 16, 2009, the Food and Drug Administration (FDA) licensed bivalent human papillomavirus vaccine (HPV2; Cervarix… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Cervarix™ is a prophylactic human papillomavirus (HPV)-16/18 vaccine developed for the prevention of cervical cancer. The vaccine… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
This observer-blind study compared the prophylactic human papillomavirus (HPV) vaccines, Cervarix (GlaxoSmithKline) and Gardasil… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2009
Review
2009
Persistent infection with human papillomavirus (HPV) is a necessary cause of cervical cancer, resulting annually in 274,000… Expand
Is this relevant?
2009
2009
Cervarix is a recombinant human papillomavirus (HPV)-16 and -18 L1 virus-like-particle (VLP) AS04-adjuvanted vaccine designed to… Expand
Is this relevant?
2008
2008
Cervical cancer of both squamous and adenocarcinoma types is considered virtually 100% attributable to human papillomavirus (HPV… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?